New approach to gene therapy
United in Purpose
To build a technological and industrial infrastructure that radically accelerates and scales the development of gene therapy technologies and their translation to the market.
NIVIRON — a new approach to gene therapy
NIVIRON is a next-generation biotechnology company developing gene therapy technologies using artificial intelligence, which we integrate into all scientific and business processes.
We work with the fundamental mechanisms of gene therapy, building a systematic process for designing viral vectors and genetic constructs, followed by the development and testing of laboratory prototypes.
The company is creating a scalable infrastructure based on the integration of computational modeling and laboratory validation. This enables us to accelerate the transition from a scientific hypothesis to functional prototypes and solutions ready for commercialization.
At the center of the company is an infrastructure for creating technologies in the field of gene therapy, integrating two elements:
Digital infrastructure
Reproduces and automates key stages in the creation of new gene therapy technologies.
Laboratory base
Used for constructing prototypes and for testing their efficacy and safety.
Infrastructure for commercial development
Ensures that validated technological prototypes are advanced to the stage of clinical trials and subsequently licensed to Big Pharma.
Get in touch
If you are developing technologies in the field of gene therapy or looking for partners for collaborative research, feel free to reach out.
